Tricyclic Indole Crystallization with Weak Organic Base

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Tricyclic indole compounds used in therapeutic and diagnostic applications often contain significant amounts of incorrect isomers, which compete with the correct isomer for biological binding, leading to reduced purity and effectiveness, especially when intended for in vivo use.

Innovation Solution

A composition comprising a tricyclic indole compound with a specific structural formula and a method involving crystallization in the presence of a catalytic amount of a weak organic base in a suitable solvent to reduce the amount of incorrect isomers to no more than 1%, enhancing purity and impurity profile.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional cyclization reaction is used to synthesize tricyclic indole compounds, then the compound can be produced, but significant amounts of incorrect isomers are formed which reduce purity

Engineering Contradiction:
Improvepurity of tricyclic indole compoundVSAvoidincorrect isomer formation
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The invention changes the chemical environment parameters by introducing a weak organic base (such as triethylamine, diisopropylethylamine, or pyridine) into the crystallization process. This parameter change modifies the crystallization behavior to enable selective incorporation of the correct isomer into the crystal lattice while excluding incorrect isomers, thereby achieving high purity (≥98%) product without requiring additional purification steps.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The weak organic base acts as an intermediary substance during crystallization. It mediates the selective crystallization process by interacting with the correct isomer to facilitate its incorporation into the crystal structure while preventing incorrect isomers from being incorporated. This intermediary enables the separation of isomers based on their different molecular properties and crystal packing behaviors.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If chromatographic purification is used to remove incorrect isomers, then purity can be improved, but the process becomes more complex and time-consuming

Engineering Contradiction:
Improvepurity of tricyclic indole compoundVSAvoidpurification process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention extracts or removes the need for complex chromatographic purification equipment and procedures. By using simple filtration and washing steps with the weak organic base during crystallization, the incorrect isomers are excluded from the crystal lattice and removed in the mother liquor, eliminating the need for time-consuming and expensive chromatographic steps while achieving ≥98% purity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention utilizes the phase transition of the correct isomer from dissolved state to crystalline state during the crystallization process. By controlling the phase transition conditions in the presence of weak organic base, the correct isomer selectively crystallizes while incorrect isomers remain in the liquid phase, enabling simple separation by filtration without requiring complex purification equipment.

Inventive Principle:
Principle #36Phase transitions

3Manufacturing precision

If multiple purification steps are performed to reduce incorrect isomers, then purity increases, but productivity decreases

Engineering Contradiction:
Improvepurity of tricyclic indole compoundVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention merges the purification function into the crystallization step itself. By combining the crystallization process with the purification function through the addition of weak organic base, the correct isomer is selectively crystallized with high purity in a single operation, eliminating the need for separate purification steps and thereby maintaining high productivity while achieving ≥98% purity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention performs preliminary purification action during the crystallization process by pre-addition of weak organic base. This preliminary action ensures that the crystal lattice is pre-configured to selectively incorporate only the correct isomer, preventing incorrect isomer incorporation before it happens, and eliminating the need for subsequent purification steps, thus maintaining high production efficiency.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly reduces the amount of incorrect isomers, resulting in a higher purity tricyclic indole compound with superior properties for therapeutic or diagnostic applications, particularly suitable for in vivo use.

Implementation Method 1

crystallization in the presence of a catalytic amount of a weak organic base in a suitable solvent

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentUS10709798B2Crystallization process of tricyclic indole derivatives
Publication Date: 2020.07.14 GE HEALTHCARE LTD
  • US10709798B2 patent drawing
  • US10709798B2 patent drawing
  • US10709798B2 patent drawing

AI summary

A composition comprising a tricyclic indole compound. The composition has a higher purity and better impurity profile than known compositions comprising said tricyclic indole compound and as a consequence has superior properties, particularly when said compound is destined for use in vivo as a therapeutic or diagnostic agent.